Sharechat Logo

LIC offers semen credit to recipients of 'hairy calves' genetic defect

Thursday 6th September 2012

Text too small?

Livestock Improvement, the New Zealand farmer-owned company that sells bull semen and provides a dairy genetics database, said it will offer a credit for recipients of a genetic defect that caused so-called 'hairy calves' to be born from the offspring of the bull called Matrix.

LIC chairman Murray King said crediting the cost of all semen and inseminations from the bull responsible doesn't amount to compensation to farmers who have the calves. There are about 900 farmers affected, with 1,500 calves carry the mutant gene.

"We stand by the decision that compensation is not appropriate but the LIC board believes that a gesture of goodwill is the right thing to do for the farmers who have daughters of the bull, Matrix," King said. The credit would extend to all inseminations from Matrix including those that resulted in healthy offspring.

"Defects of this nature are rare - this is only the second of this type to have occurred in more than 50 years of LIC breeding more than 9,000 bulls," he said.

LIC has recommended the animals be tested and has offered free DNA testing.

LIC shares can be traded among farmers via the NZX platform and were last at $4.90, having fallen 2 percent this year.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors